TY - JOUR
T1 - Evidence-based clinical practice guideline on antibiotic use for the urgent management of pulpal- and periapical-related dental pain and intraoral swelling
T2 - A report from the American Dental Association
AU - Lockhart, Peter B.
AU - Tampi, Malavika P.
AU - Abt, Elliot
AU - Aminoshariae, Anita
AU - Durkin, Michael J.
AU - Fouad, Ashraf F.
AU - Gopal, Prerna
AU - Hatten, Benjamin W.
AU - Kennedy, Erinne
AU - Lang, Melanie S.
AU - Patton, Lauren L.
AU - Paumier, Thomas
AU - Suda, Katie J.
AU - Pilcher, Lauren
AU - Urquhart, Olivia
AU - O'Brien, Kelly K.
AU - Carrasco-Labra, Alonso
N1 - Funding Information:
Disclosure. Dr. Durkin receives salary support from the Centers for Disease Control and Prevention , the National Institutes for Health , and the Missouri Department of Health and Senior Services. Dr. Fouad receives funding from the Foundation for Endodontics . Dr. Lockhart receives funding from the National Institutes of Health . Dr. Patton receives grant funding from the National Institute of Dental and Craniofacial Research ; she is the president of the American Academy of Oral Medicine; a member of the ADA Council on Scientific Affairs; the coeditor of The ADA Practical Guide to Patients With Medical Conditions; and the oral medicine section editor of Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. Dr. Suda receives funding from the Agency for Healthcare Research and Quality , the Centers for Disease Control and Prevention , the National Institutes of Health , the Veterans Affairs Health Services Research and Division, the Veterans Affairs Office of Rehabilitation Research and Development , and the Veterans Affairs Quality Enhancement Research Initiative . Drs. Abt, Aminoshariae, Gopal, Hatten, Kennedy, Lang, and Paumier and Ms. O’Brien did not report any disclosures.
Funding Information:
Methodologists from the American Dental Association Center for Evidence-Based Dentistry led the development and authorship of the systematic review and clinical practice guideline in collaboration with the expert panel. The American Dental Association Council on Scientific Affairs commissioned this work. This study was funded by the American Dental Association. The authors acknowledge the special contributions of Jeff Huber, MBA, and Tyharrie Woods, MA, of the Science Institute, American Dental Association, Chicago, IL, and Laura Pontillo, ADA Library & Archives, Chicago, IL. The authors also acknowledge Michele Junger, DDS, MPH, Division of Oral Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, the ADA Council on Scientific Affairs’ Clinical Excellence Subcommittee; Marcelo W.B. Araujo, DDS, MS, PhD, Ruth Lipman, PhD, Jim Lyznicki, MS, MPH, Roger Connolly, Anita Mark, and Sarah Pahlke, MSc, from the Science Institute, ADA, Chicago, IL; Jay Elkareh, PharmD, PhD, previously with the ADA; Hannah Cho, BS, dental student at Midwestern University College of Dental Medicine-Illinois, Chicago, IL; the ADA Council on Scientific Affairs, the ADA Council on Advocacy for Access and Prevention, and the ADA Council on Dental Practice; Centers for Disease Control and Prevention; American College of Emergency Physicians; American Association of Oral and Maxillofacial Surgeons; American Association of Endodontists; American Pharmacists Association; American Academy of Physician Assistants; American Association of Public Health Dentistry; National Institute of Dental and Craniofacial Research; American Academy of Periodontology; American Academy of Oral Medicine; American Association of Nurse Practitioners; Organization for Safety, Asepsis and Prevention; Veterans Health Administration Office of Dentistry; Infectious Diseases Society of America; Society of Infectious Disease Pharmacists; Dwayne Boyers, M.Econ. Sc, PhD, University of Aberdeen, Aberdeen, Scotland; Radhika Tampi, MHS, Inova, Fairfax, VA; Anwen Cope, BDS, PhD, MPH, Cardiff University, Cardiff, Wales; Douglas Stirling, BSc, PhD, Samantha Rutherford, BSc, PhD, and Michele West, BSc, PhD from the Scottish Dental Clinical Effectiveness Programme, Dundee, Scotland.
Publisher Copyright:
© 2019 American Dental Association
PY - 2019/11
Y1 - 2019/11
N2 - Background: An expert panel convened by the American Dental Association Council on Scientific Affairs and the Center for Evidence-Based Dentistry conducted a systematic review and formulated clinical recommendations for the urgent management of symptomatic irreversible pulpitis with or without symptomatic apical periodontitis, pulp necrosis and symptomatic apical periodontitis, or pulp necrosis and localized acute apical abscess using antibiotics, either alone or as adjuncts to definitive, conservative dental treatment (DCDT) in immunocompetent adults. Types of Studies Reviewed: The authors conducted a search of the literature in MEDLINE, Embase, the Cochrane Library, and the Cumulative Index to Nursing and Allied Health Literature to retrieve evidence on benefits and harms associated with antibiotic use. The authors used the Grading of Recommendations Assessment, Development and Evaluation approach to assess the certainty in the evidence and the Evidence-to-Decision framework. Results: The panel formulated 5 clinical recommendations and 2 good practice statements, each specific to the target conditions, for settings in which DCDT is and is not immediately available. With likely negligible benefits and potentially large harms, the panel recommended against using antibiotics in most clinical scenarios, irrespective of DCDT availability. They recommended antibiotics in patients with systemic involvement (for example, malaise or fever) due to the dental conditions or when the risk of experiencing progression to systemic involvement is high. Conclusion and Practical Implications: Evidence suggests that antibiotics for the target conditions may provide negligible benefits and probably contribute to large harms. The expert panel suggests that antibiotics for target conditions be used only when systemic involvement is present and that immediate DCDT should be prioritized in all cases.
AB - Background: An expert panel convened by the American Dental Association Council on Scientific Affairs and the Center for Evidence-Based Dentistry conducted a systematic review and formulated clinical recommendations for the urgent management of symptomatic irreversible pulpitis with or without symptomatic apical periodontitis, pulp necrosis and symptomatic apical periodontitis, or pulp necrosis and localized acute apical abscess using antibiotics, either alone or as adjuncts to definitive, conservative dental treatment (DCDT) in immunocompetent adults. Types of Studies Reviewed: The authors conducted a search of the literature in MEDLINE, Embase, the Cochrane Library, and the Cumulative Index to Nursing and Allied Health Literature to retrieve evidence on benefits and harms associated with antibiotic use. The authors used the Grading of Recommendations Assessment, Development and Evaluation approach to assess the certainty in the evidence and the Evidence-to-Decision framework. Results: The panel formulated 5 clinical recommendations and 2 good practice statements, each specific to the target conditions, for settings in which DCDT is and is not immediately available. With likely negligible benefits and potentially large harms, the panel recommended against using antibiotics in most clinical scenarios, irrespective of DCDT availability. They recommended antibiotics in patients with systemic involvement (for example, malaise or fever) due to the dental conditions or when the risk of experiencing progression to systemic involvement is high. Conclusion and Practical Implications: Evidence suggests that antibiotics for the target conditions may provide negligible benefits and probably contribute to large harms. The expert panel suggests that antibiotics for target conditions be used only when systemic involvement is present and that immediate DCDT should be prioritized in all cases.
KW - Antibiotics
KW - antibiotic stewardship
KW - clinical practice guideline
KW - localized acute apical abscess
KW - pulp necrosis
KW - symptomatic apical periodontitis
KW - symptomatic irreversible pulpitis
UR - http://www.scopus.com/inward/record.url?scp=85073749053&partnerID=8YFLogxK
U2 - 10.1016/j.adaj.2019.08.020
DO - 10.1016/j.adaj.2019.08.020
M3 - Article
C2 - 31668170
AN - SCOPUS:85073749053
SN - 0002-8177
VL - 150
SP - 906-921.e12
JO - Journal of the American Dental Association
JF - Journal of the American Dental Association
IS - 11
ER -